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268a Monday, February 17, 2014while curvature sensing is generally conserved throughout themembrane binding
region of aSyn, curvature generation requires specific binding domains. These re-
sults will help to form amodel for the interplay between aSynmembrane binding
activity and membrane remodeling andmay have implications for understanding
both aSyn’s native role as well as its contribution to PD.
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a-Synuclein is an intrinsically disordered protein that is preferentially ex-
pressed in presynaptic nerve terminals. It undergoes a large-scale conforma-
tional rearrangement upon binding to synaptic vesicle membranes. In order
to obtain the structural insights into the membrane-bound a-synuclein at the
residue-specific resolution, we incorporated single tryptophan at various loca-
tions along the sequence. These tryptophans were used as site-specific fluores-
cence markers to characterize the structural and dynamical aspects of
a-synuclein. The spatial localization of various parts of the protein near the
membrane surface was elucidated utilizing a unique and sensitive fluorescence
readout, namely, red-edge excitation shift (REES), which originates when a flu-
orophore is located in a highly ordered micro-environment. The extent of REES
observed at different locations allowed us to directly identify the residues that
are localized at the membrane-water interface comprising a thin (~15 A˚) layer
of motionally-constrained water molecules (Figure 1). Additionally, we have
been able to distinguish subtle but impor-
tant structural differences of a-synuclein
bound to different lipids membranes. We
believe that the structural modulations of
a-synuclein on the membrane could
potentially be related to its physiological
functions as well as to the onset of Parkin-
son’s diseases.1361-Pos Board B91
Determination of Primary Nucleation Mechanisms of a-Synuclein
Amyloid Aggregation
Francesco A. Aprile, Georg Meisl, Alexander K. Buell, Patrick Flagmeier,
Christopher M. Dobson, Michele Vendruscolo, Tuomas P.J. Knowles.
University of Cambridge, Cambridge, United Kingdom.
Protein conformational diseases represent a class of pathologies in which spe-
cific peptides or proteins form aberrant self-assemblies that constitute the hall-
mark of several neurodegenerative diseases. Specifically, the formation of
intra-neuronal inclusions of the protein a-synuclein (aSyn) is associated with
the pathogenesis of Parkinson’s disease (PD).
A great interest is in the early stages of aSyn aggregation, for which soluble
monomeric proteins are converted into fibrillar nanostructures. It has been
shown that at these stages many parallel and competing pathways take contem-
poraneously place and it is currently very difficult to address on these mecha-
nisms by using standard techniques of molecular investigations. In order to
overcome the limitations of standard approaches, we employed ensemble-
averaged kinetic studies coupled with microdloplet technology in order to char-
acterize the primary nucleation early stages of aSyn amyloid formation and
therefore to elucidate the fundamental mechanisms underlying this phenome-
non. Testing different aggregation conditions, we have been able to understand
that the primary nucleation mechanism underlying aSyn aggregation is not ho-
mogeneous, whereas it is catalysed by different factors, including air/water sur-
face interactions.
The full characterization of all the processes involved in the aggregation mech-
anism of aSyn will be fundamental for devising new and innovative therapeutic
strategies against PD. Indeed, based on our analysis, we expect that it will be
possible to design and screen pharmacological compounds able to selectively
inhibit the nucleation steps that trigger either the overall of the process or spe-
cifically the formation of the toxic aggregated species.
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Alpha-synuclein is a small intracellular protein naturally abundant in the brain
at low-micromolar concentrations. Its fibrillar aggregates are the major constit-
uents of intracellular inclusions, known as Lewy bodies, which are the patho-
logical hallmarks of Parkinson disease and related neurodegenerative disorders.
However, increasing evidence suggest that oligomers, rather than fibrils, are themost toxic and damaging to brain neurons. Single molecule FRET can be used
to detect and characterise the low levels of heterogeneous oligomers formed
during protein aggregation. In this presentation, I will discuss the recent results
of in-vitro studies of alpha-synuclein oligomer formation at physiologically-
relevant concentrations using single-molecule FRET spectroscopy and show
how these experiments reveal the key microscopic reactions taking place dur-
ing the aggregation of alpha-synuclein.
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It is currently unclear how the crowded cellular milieu affects the structural dis-
tributions of intrinsically disordered proteins (IDPs). Here we employ single-
molecule Fo¨rster resonance energy transfer (FRET) to quantify the effect of
molecular crowding on four disordered proteins with very different degrees
of charge-induced expansion. For a variety of crowding agents (PEG, PVP,
Dextran, PVA), an increasing collapse of the polypeptide chains is observed
with increasing concentrations of crowder, as expected from simple consider-
ations, such as scaled particle theory. However, we also observe an increasing
collapse with increasing size of the crowder, the opposite of what scaled parti-
cle theory predicts.
Interestingly, the observations can be rationalized quantitatively within the
framework of Flory-Huggins theories that take into account the polymeric
properties of both the disordered proteins and the crowder. The results provide
a step towards understanding the behavior of IDPs and denatured proteins in the
presence of polydisperse co-solutes as those characteristic of the cellular
environment.
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The pathological hallmark of Parkinson’s disease is the presence of insoluble
protein deposits in the brain, which are formed when specific protein molecules
misfold and aggregate into highly ordered fibrils. In Parkinson’s disease, the
deposits are primarily made up of alpha-synuclein, a protein whose major func-
tion is not fully known. Rather than the fibrils themselves being toxic, evidence
now points towards the smaller, soluble oligomers formed in the initial stages
of the process as being the culprit. We have developed a novel single-molecule
fluorescence technique to detect and characterise the oligomers of alpha-
synuclein. Using this methodology, we are able to identify the cytotoxic spe-
cies, and apply these species to primary neuronal cultures to investigate their
damaging effects.
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Alpha-Synuclein (aS) is a 140 aa intrinsically disordered and amyloidogenic
protein. Its physiological functions are unclear, but are believed to be con-
nected to the interaction with synaptic vesicles or membranes of other
organelles.
The sequence of aS shows partial 11 amino acid periodicity that induces atypical
3/11 helix conformation on membranes. Fluorescence studies of tryptophan mu-
tants of aSpoint to a flexible breakat residues 52-54 between two helical domains.
Deletion of this flexible 4 aa fragment between two groups of 11 aa repeats does
not significantly affect aS membrane binding but strongly decreases the protein
aggregation and fibril formation propensity. Moreover, the deletion mutant in-
hibits aggregation of wildtype aS, likely by hindering the fibril growth, since
the mutant does not appear to co-aggregate into fibrils with wt aS.
Introducing additional 11 amino acid repeats into the aS sequence increases af-
finity of themodified protein tomembranes and slows down the protein aggrega-
tion. We believe that the 11 amino acid
repeats in the aS sequence play a key role
in aS’s ability to switch between a helical
conformation on membranes and b-sheets
in fibrils.
